nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—CYP1A2—type 2 diabetes mellitus	0.208	0.607	CbGaD
Lumiracoxib—PTGS2—type 2 diabetes mellitus	0.135	0.393	CbGaD
Lumiracoxib—UGT1A9—Nateglinide—type 2 diabetes mellitus	0.0712	0.124	CbGbCtD
Lumiracoxib—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.039	0.0677	CbGbCtD
Lumiracoxib—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.039	0.0677	CbGbCtD
Lumiracoxib—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.036	0.0625	CbGbCtD
Lumiracoxib—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0296	0.0513	CbGbCtD
Lumiracoxib—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0284	0.0492	CbGbCtD
Lumiracoxib—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0222	0.0386	CbGbCtD
Lumiracoxib—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0217	0.0377	CbGbCtD
Lumiracoxib—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0199	0.0345	CbGbCtD
Lumiracoxib—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0189	0.0328	CbGbCtD
Lumiracoxib—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0189	0.0328	CbGbCtD
Lumiracoxib—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0185	0.0321	CbGbCtD
Lumiracoxib—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0174	0.0303	CbGbCtD
Lumiracoxib—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0168	0.0292	CbGbCtD
Lumiracoxib—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0161	0.0279	CbGbCtD
Lumiracoxib—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0157	0.0273	CbGbCtD
Lumiracoxib—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0157	0.0273	CbGbCtD
Lumiracoxib—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0145	0.0252	CbGbCtD
Lumiracoxib—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.014	0.0243	CbGbCtD
Lumiracoxib—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0128	0.0222	CbGbCtD
Lumiracoxib—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0127	0.022	CbGbCtD
Lumiracoxib—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.012	0.0208	CbGbCtD
Lumiracoxib—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0119	0.0207	CbGbCtD
Lumiracoxib—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0114	0.0198	CbGbCtD
Lumiracoxib—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00967	0.0168	CbGbCtD
Lumiracoxib—CYP2C19—Losartan—type 2 diabetes mellitus	0.00884	0.0153	CbGbCtD
Lumiracoxib—CYP1A2—Losartan—type 2 diabetes mellitus	0.00816	0.0142	CbGbCtD
Lumiracoxib—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00804	0.014	CbGbCtD
Lumiracoxib—CYP2C9—Losartan—type 2 diabetes mellitus	0.00735	0.0128	CbGbCtD
Lumiracoxib—PTGS2—leg—type 2 diabetes mellitus	0.000721	0.133	CbGeAlD
Lumiracoxib—PTGS2—hindlimb—type 2 diabetes mellitus	0.000644	0.119	CbGeAlD
Lumiracoxib—UGT1A9—kidney—type 2 diabetes mellitus	0.000534	0.0985	CbGeAlD
Lumiracoxib—Bromfenac—PTGS2—type 2 diabetes mellitus	0.000414	0.196	CrCbGaD
Lumiracoxib—PTGS1—artery—type 2 diabetes mellitus	0.000413	0.0762	CbGeAlD
Lumiracoxib—PTGS2—artery—type 2 diabetes mellitus	0.000395	0.0728	CbGeAlD
Lumiracoxib—PTGS1—endothelium—type 2 diabetes mellitus	0.000349	0.0644	CbGeAlD
Lumiracoxib—UGT1A9—liver—type 2 diabetes mellitus	0.000337	0.0623	CbGeAlD
Lumiracoxib—PTGS2—endothelium—type 2 diabetes mellitus	0.000333	0.0615	CbGeAlD
Lumiracoxib—Tolmetin—PTGS2—type 2 diabetes mellitus	0.000278	0.132	CrCbGaD
Lumiracoxib—Meclofenamic acid—PTGS2—type 2 diabetes mellitus	0.000274	0.13	CrCbGaD
Lumiracoxib—Diclofenac—CYP2E1—type 2 diabetes mellitus	0.000249	0.118	CrCbGaD
Lumiracoxib—Diclofenac—CYP1A2—type 2 diabetes mellitus	0.000236	0.112	CrCbGaD
Lumiracoxib—Mefenamic acid—PTGS2—type 2 diabetes mellitus	0.000213	0.101	CrCbGaD
Lumiracoxib—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.00019	0.035	CbGeAlD
Lumiracoxib—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000157	0.029	CbGeAlD
Lumiracoxib—Diclofenac—CYP3A4—type 2 diabetes mellitus	0.000157	0.0741	CrCbGaD
Lumiracoxib—Diclofenac—PTGS2—type 2 diabetes mellitus	0.000153	0.0726	CrCbGaD
Lumiracoxib—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000143	0.0265	CbGeAlD
Lumiracoxib—PTGS1—kidney—type 2 diabetes mellitus	0.00014	0.0259	CbGeAlD
Lumiracoxib—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000137	0.0253	CbGeAlD
Lumiracoxib—Diclofenac—ALB—type 2 diabetes mellitus	0.000137	0.0647	CrCbGaD
Lumiracoxib—PTGS2—kidney—type 2 diabetes mellitus	0.000134	0.0248	CbGeAlD
Lumiracoxib—PTGS2—pancreas—type 2 diabetes mellitus	0.000133	0.0246	CbGeAlD
Lumiracoxib—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000126	0.0234	CbGeAlD
Lumiracoxib—CYP2C19—liver—type 2 diabetes mellitus	0.000125	0.0231	CbGeAlD
Lumiracoxib—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000121	0.0223	CbGeAlD
Lumiracoxib—CYP1A2—liver—type 2 diabetes mellitus	0.000102	0.0189	CbGeAlD
Lumiracoxib—CYP2C9—liver—type 2 diabetes mellitus	9.72e-05	0.0179	CbGeAlD
Lumiracoxib—PTGS2—liver—type 2 diabetes mellitus	8.48e-05	0.0157	CbGeAlD
Lumiracoxib—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	8.77e-06	0.000121	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8.73e-06	0.00012	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	8.71e-06	0.00012	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CALM1—type 2 diabetes mellitus	8.64e-06	0.000119	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	8.62e-06	0.000119	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—APOE—type 2 diabetes mellitus	8.61e-06	0.000119	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	8.58e-06	0.000118	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	8.53e-06	0.000118	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	8.53e-06	0.000118	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—APOA1—type 2 diabetes mellitus	8.51e-06	0.000117	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	8.47e-06	0.000117	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	8.47e-06	0.000117	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.46e-06	0.000117	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	8.45e-06	0.000117	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	8.38e-06	0.000116	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—APOB—type 2 diabetes mellitus	8.32e-06	0.000115	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	8.29e-06	0.000114	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	8.29e-06	0.000114	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	8.24e-06	0.000114	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	8.2e-06	0.000113	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	8.19e-06	0.000113	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	8.17e-06	0.000113	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	8.12e-06	0.000112	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	8.12e-06	0.000112	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	8.1e-06	0.000112	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	8.04e-06	0.000111	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	8.03e-06	0.000111	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	7.96e-06	0.00011	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	7.96e-06	0.00011	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—LPL—type 2 diabetes mellitus	7.94e-06	0.00011	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.92e-06	0.000109	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	7.91e-06	0.000109	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	7.91e-06	0.000109	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	7.91e-06	0.000109	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	7.87e-06	0.000108	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	7.86e-06	0.000108	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	7.77e-06	0.000107	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	7.76e-06	0.000107	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	7.76e-06	0.000107	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	7.76e-06	0.000107	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	7.76e-06	0.000107	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	7.72e-06	0.000107	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	7.64e-06	0.000105	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	7.56e-06	0.000104	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	7.54e-06	0.000104	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PPARG—type 2 diabetes mellitus	7.5e-06	0.000103	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	7.46e-06	0.000103	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	7.45e-06	0.000103	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	7.44e-06	0.000103	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	7.41e-06	0.000102	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	7.41e-06	0.000102	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	7.4e-06	0.000102	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—INS—type 2 diabetes mellitus	7.36e-06	0.000101	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CCR5—type 2 diabetes mellitus	7.32e-06	0.000101	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.3e-06	0.000101	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	7.3e-06	0.000101	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	7.27e-06	0.0001	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	7.26e-06	0.0001	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.23e-06	9.97e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.22e-06	9.96e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	7.22e-06	9.95e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	7.22e-06	9.95e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	7.22e-06	9.95e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	7.17e-06	9.89e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	7.17e-06	9.89e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	7.17e-06	9.88e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	7.15e-06	9.86e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	7.12e-06	9.82e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	7.1e-06	9.79e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	7.1e-06	9.79e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	7.1e-06	9.79e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.08e-06	9.77e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	7.05e-06	9.72e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	7.04e-06	9.72e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	7.02e-06	9.68e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7e-06	9.66e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	6.97e-06	9.61e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	6.96e-06	9.61e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	6.96e-06	9.6e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	6.94e-06	9.57e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	6.92e-06	9.54e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	6.91e-06	9.52e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	6.82e-06	9.4e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.81e-06	9.39e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IRS2—type 2 diabetes mellitus	6.8e-06	9.38e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	6.77e-06	9.34e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	6.76e-06	9.32e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ALB—type 2 diabetes mellitus	6.75e-06	9.3e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CALM1—type 2 diabetes mellitus	6.68e-06	9.21e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—APOE—type 2 diabetes mellitus	6.66e-06	9.18e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	6.65e-06	9.17e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—APOA1—type 2 diabetes mellitus	6.58e-06	9.08e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	6.51e-06	8.98e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	6.49e-06	8.96e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.49e-06	8.95e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	6.49e-06	8.95e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	6.47e-06	8.93e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	6.47e-06	8.93e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	6.47e-06	8.93e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	6.46e-06	8.91e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NOS3—type 2 diabetes mellitus	6.45e-06	8.9e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3R1—type 2 diabetes mellitus	6.45e-06	8.9e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	6.42e-06	8.85e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	6.42e-06	8.85e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	6.35e-06	8.76e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	6.33e-06	8.73e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	6.33e-06	8.73e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	6.32e-06	8.71e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	6.3e-06	8.68e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	6.26e-06	8.64e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	6.24e-06	8.61e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.23e-06	8.59e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.21e-06	8.56e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	6.21e-06	8.56e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOS2—type 2 diabetes mellitus	6.2e-06	8.55e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.17e-06	8.51e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	6.17e-06	8.51e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	6.17e-06	8.51e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	6.17e-06	8.51e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	6.16e-06	8.5e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	6.15e-06	8.49e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	6.15e-06	8.49e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	6.13e-06	8.45e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	6.12e-06	8.44e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	6.02e-06	8.3e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—INS—type 2 diabetes mellitus	6e-06	8.27e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	5.99e-06	8.26e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	5.95e-06	8.21e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IRS1—type 2 diabetes mellitus	5.94e-06	8.19e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	5.92e-06	8.17e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGS2—type 2 diabetes mellitus	5.9e-06	8.14e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	5.87e-06	8.1e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	5.85e-06	8.07e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	5.85e-06	8.07e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	5.71e-06	7.87e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	5.69e-06	7.85e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—INS—type 2 diabetes mellitus	5.69e-06	7.84e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.68e-06	7.83e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	5.61e-06	7.74e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	5.61e-06	7.74e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	5.59e-06	7.72e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	5.57e-06	7.69e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.55e-06	7.65e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	5.53e-06	7.63e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	5.53e-06	7.63e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	5.53e-06	7.63e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	5.51e-06	7.6e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	5.5e-06	7.59e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—AKT2—type 2 diabetes mellitus	5.5e-06	7.58e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	5.43e-06	7.49e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	5.38e-06	7.42e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.31e-06	7.32e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.3e-06	7.32e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	5.3e-06	7.32e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	5.28e-06	7.28e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	5.27e-06	7.26e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.26e-06	7.26e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	5.26e-06	7.26e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	5.22e-06	7.2e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	5.21e-06	7.19e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	5.06e-06	6.98e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	5.06e-06	6.98e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	5e-06	6.9e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	4.99e-06	6.88e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOS3—type 2 diabetes mellitus	4.99e-06	6.88e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	4.92e-06	6.79e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	4.88e-06	6.73e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	4.86e-06	6.7e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.85e-06	6.69e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.84e-06	6.67e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.84e-06	6.67e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	4.83e-06	6.66e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.81e-06	6.64e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	4.81e-06	6.64e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	4.8e-06	6.61e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	4.8e-06	6.61e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—INS—type 2 diabetes mellitus	4.76e-06	6.57e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.75e-06	6.55e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	4.73e-06	6.52e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	4.71e-06	6.5e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	4.61e-06	6.36e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	4.59e-06	6.33e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	4.53e-06	6.25e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	4.49e-06	6.19e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	4.4e-06	6.07e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	4.37e-06	6.02e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	4.35e-06	6e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	4.31e-06	5.95e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	4.3e-06	5.93e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	4.27e-06	5.88e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	4.18e-06	5.77e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	4.18e-06	5.76e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.18e-06	5.76e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.13e-06	5.7e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	4.13e-06	5.7e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	4.13e-06	5.7e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	4.13e-06	5.7e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	4.11e-06	5.68e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	4.06e-06	5.6e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	4.06e-06	5.6e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	4.05e-06	5.58e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	4e-06	5.52e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.97e-06	5.47e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	3.94e-06	5.44e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.89e-06	5.37e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.83e-06	5.29e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.77e-06	5.2e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	3.76e-06	5.19e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.7e-06	5.11e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.69e-06	5.09e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SRC—type 2 diabetes mellitus	3.69e-06	5.09e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.68e-06	5.08e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	3.67e-06	5.06e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.65e-06	5.03e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	3.58e-06	4.93e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.53e-06	4.87e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	3.53e-06	4.86e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	3.46e-06	4.77e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.39e-06	4.67e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.32e-06	4.58e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	3.3e-06	4.55e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—EGFR—type 2 diabetes mellitus	3.23e-06	4.46e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	3.22e-06	4.44e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	3.22e-06	4.43e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	3.17e-06	4.37e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	3.17e-06	4.37e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	3.15e-06	4.35e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	3.15e-06	4.35e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	3.12e-06	4.3e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	3.03e-06	4.18e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	3.03e-06	4.18e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—AKT1—type 2 diabetes mellitus	2.97e-06	4.09e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.89e-06	3.99e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.77e-06	3.83e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.77e-06	3.81e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.77e-06	3.81e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.75e-06	3.79e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.69e-06	3.72e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.53e-06	3.49e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6—type 2 diabetes mellitus	2.48e-06	3.43e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.47e-06	3.41e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	2.42e-06	3.34e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.36e-06	3.26e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.36e-06	3.26e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—AKT1—type 2 diabetes mellitus	2.29e-06	3.16e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.16e-06	2.98e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	1.92e-06	2.65e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.39e-06	1.92e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.27e-06	1.75e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.09e-06	1.5e-05	CbGpPWpGaD
